세계의 의료 분야 AI 시장 보고서(2025년)
Artificial Intelligence In Medicine Global Market Report 2025
상품코드 : 1824587
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료 분야 AI 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 38.9%를 나타내 581억 6,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 만성질환의 유병률 상승, 디지털 전환 실천의 채용이 중시되게 되어 있기 때문입니다. 예측 기간의 주요 동향으로는 의료 로봇 개발, 환자 관리 애플리케이션의 도입으로 인한 상당한 성장, 의약품의 AI, 정밀의료 진전 등이 있습니다.

향후 5년간의 성장률이 38.9%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 이스라엘과 에스토니아에서 개발된 인공지능(AI) 기반 감별 진단 생성기 및 치료 권장 엔진 가격을 늘리고 진단 불확실성을 늘리고 의료 시스템 비용을 상승시켜 미국의 임상적 의사결정을 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

실시간 원격 환자 모니터링(RPM) 시스템에 대한 관심 증가는 의료 분야 AI의 발전을 촉진하고 있습니다. RPM 시스템을 통해 의료 서비스 제공업체는 원격지에서 환자의 건강 상태를 모니터링할 수 있어 전통적인 의료 환경을 넘어 지속적인 관리가 용이해집니다. 의료의 AI는 대량의 환자 데이터를 처리함으로써 RPM을 강화하고, 예측 인사이트를 가능하게 하고, 잠재적인 건강 문제를 조기에 발견하고, 개별화된 케어 플랜을 지원합니다. 예를 들어, 캐나다 통계국이 2024년 11월에 보고한 바에 따르면, 브리티시컬럼비아주(73.8%)와 뉴펀들랜드 래브라도주(70.7%)의 캐나다인은 가상 진찰의 이용률이 높아, 원격지나 가상 헬스케어에의 변화를 부각했습니다. 이러한 RPM 시스템에 대한 관심 증가는 결과적으로 의료 분야 AI 애플리케이션의 성장에 박차를 가하고, 보다 신속하고 데이터 중심의 건강 관리 제공을 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Artificial intelligence in medicine involves the application of technologies such as machine learning and data analysis to improve diagnosis, treatment, and healthcare management. It facilitates faster and more accurate disease detection, personalized treatment plans, and increased overall efficiency in medical processes.

The primary types of artificial intelligence in medicine encompass hardware, software, and services. Hardware components, including multi-purpose computers, embedded motherboards, and fanless embedded systems, serve as crucial building blocks for medical devices relying on AI. Various technologies, such as machine learning, natural language processing, context-aware processing, and computer vision, find applications in medical administration and support, patient management, research and development, and other domains. These applications cater to diverse end-users, including hospitals, clinics, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The artificial intelligence in medicine market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in medicine market statistics, including artificial intelligence in medicine industry global market size, regional shares, competitors with artificial intelligence in medicine market share, detailed artificial intelligence in medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence in medicine industry. This artificial intelligence in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in medicine market size has grown exponentially in recent years. It will grow from $11.19 billion in 2024 to $15.6 billion in 2025 at a compound annual growth rate (CAGR) of 39.4%. The growth in the historic period can be attributed to increased emphasis on ensuring patient well-being and relative shortage of physicians, increase of skilled healthcare professionals, increase in the processing power of ai systems.

The artificial intelligence in medicine market size is expected to see exponential growth in the next few years. It will grow to $58.16 billion in 2029 at a compound annual growth rate (CAGR) of 38.9%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, growing emphasis on the adoption of digital transformation practices. Major trends in the forecast period include development of medical robots, introducing patient management application to witness significant growth, ai in drug discovery and advance precision medicine.

The forecast of 38.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. clinical decision-making by inflating prices of Artificial intelligence(AI)-based differential diagnosis generators and treatment recommendation engines developed in Israel and Estonia, resulting in prolonged diagnostic uncertainty and higher healthcare system costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing interest in real-time remote patient monitoring (RPM) systems is driving advancements in artificial intelligence (AI) within the medical field. RPM systems allow healthcare providers to monitor patients' health remotely, facilitating continuous care beyond traditional healthcare settings. AI in medicine enhances RPM by processing large volumes of patient data, enabling predictive insights, detecting potential health issues early, and supporting personalized care plans. For instance, Statistics Canada reported in November 2024 that Canadians in British Columbia (73.8%) and Newfoundland and Labrador (70.7%) had high usage of virtual consultations, highlighting the shift towards remote and virtual healthcare. This increasing interest in RPM systems is consequently fueling growth in AI applications within the medical industry, supporting more responsive and data-driven healthcare delivery.

Leading companies operating in the artificial intelligence in the medicine market are directing their efforts towards the development of innovative solutions, exemplified by AI-powered platforms, to deliver reliable services to customers. An AI-powered platform refers to a software solution that incorporates artificial intelligence (AI) technologies to automate tasks, analyze data, and make predictions. In April 2023, OM1 Inc., a U.S.-based digital health company, introduced PhenOM. Leveraging real-world data and advanced analytics, PhenOM identifies unique digital phenotypes associated with conditions and outcomes, creating distinct fingerprints for different patient groups. This platform analyzes individual patient data to predict risks, identify opportunities for intervention, and inform treatment decisions.

In July 2024, GE HealthCare, a U.S.-based medical technology company, acquired the clinical artificial intelligence (AI) software business of Intelligent Ultrasound Group PLC for approximately $51 million. This acquisition aligns with GE HealthCare's strategy to strengthen its ultrasound portfolio by incorporating advanced AI-driven image recognition technology, enhancing the accuracy and efficiency of ultrasound exams in patient care. Intelligent Ultrasound Group PLC, based in the U.K., specializes in AI-based clinical image analysis tools designed to support diagnostic ultrasound, making it a valuable addition to GE HealthCare's expanding capabilities in medical imaging.

Major companies operating in the artificial intelligence in medicine market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

North America was the largest region in the artificial intelligence in medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in the medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in the medicine market consists of revenues earned by entities by providing services such as diagnostic assistance, drug discovery and development, patient management, and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the medicine market also includes sales of diagnostic imaging devices, smart medical devices, and genomic sequencing equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for artificial intelligence in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Medicine Market Characteristics

3. Artificial Intelligence In Medicine Market Trends And Strategies

4. Artificial Intelligence In Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Artificial Intelligence In Medicine Growth Analysis And Strategic Analysis Framework

6. Artificial Intelligence In Medicine Market Segmentation

7. Artificial Intelligence In Medicine Market Regional And Country Analysis

8. Asia-Pacific Artificial Intelligence In Medicine Market

9. China Artificial Intelligence In Medicine Market

10. India Artificial Intelligence In Medicine Market

11. Japan Artificial Intelligence In Medicine Market

12. Australia Artificial Intelligence In Medicine Market

13. Indonesia Artificial Intelligence In Medicine Market

14. South Korea Artificial Intelligence In Medicine Market

15. Western Europe Artificial Intelligence In Medicine Market

16. UK Artificial Intelligence In Medicine Market

17. Germany Artificial Intelligence In Medicine Market

18. France Artificial Intelligence In Medicine Market

19. Italy Artificial Intelligence In Medicine Market

20. Spain Artificial Intelligence In Medicine Market

21. Eastern Europe Artificial Intelligence In Medicine Market

22. Russia Artificial Intelligence In Medicine Market

23. North America Artificial Intelligence In Medicine Market

24. USA Artificial Intelligence In Medicine Market

25. Canada Artificial Intelligence In Medicine Market

26. South America Artificial Intelligence In Medicine Market

27. Brazil Artificial Intelligence In Medicine Market

28. Middle East Artificial Intelligence In Medicine Market

29. Africa Artificial Intelligence In Medicine Market

30. Artificial Intelligence In Medicine Market Competitive Landscape And Company Profiles

31. Artificial Intelligence In Medicine Market Other Major And Innovative Companies

32. Global Artificial Intelligence In Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Medicine Market

34. Recent Developments In The Artificial Intelligence In Medicine Market

35. Artificial Intelligence In Medicine Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기